Expres2ion Biotechnologies ApS

Private limited companyCVR 32770487HørsholmActive

Expres2ion Biotechnologies ApS is a private limited company, based in Hørsholm, active in research and experimental development on natural sciences and engineering, founded in 2010. The company made a loss in both 2024 and 2025, most recently DKK 21.9m. With 20 employees, the company is about 4 times larger than the industry median. Equity fell to DKK 24m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 9.2m+61.9% vs. 2024
Net profit−DKK 21.9m−10.7% vs. 2024
EquityDKK 24m−27% vs. 2024
Employees20latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 19.8m to DKK 21.9m (2024 → 2025).
  • Equity fell 27% (2024 → 2025), to DKK 24m.

Employees

  • 4 fewer employees than a year earlier: 20 (08/2026) against 24 (08/2025).

Management and owners, last 24 months

  • New in management: Michel Jean Baijot (board member, 01/04/2026).
  • Stepped down: Sara Sande (board member, 01/04/2026).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 80m−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100m202020212022202320242025
EquityNet profit
Financial figures for Expres2ion Biotechnologies ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−7,044−7,806−57,917−38,920−24,035−9,158+61.9%
Operating profit (EBIT)–−29,791−84,344−64,611−40,311−25,969+35.6%
Profit before tax−20,406−29,733−84,649−61,130−25,331−25,994−2.6%
Net profit−18,365−27,225−79,149−55,629−19,831−21,948−10.7%
Total assets81,750106,37991,01750,21057,97443,557−24.9%
Equity64,35097,26868,53241,93132,79823,950−27%
Liabilities17,4019,11122,4858,27925,17519,606−22.1%
Cash and cash equivalents75,42323,18974,27436,40243,37232,598−24.8%
Average number of employees162127261718+5.9%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 60m−DKK 50m−DKK 40m−DKK 30m−DKK 20m−DKK 10mDKK 0202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Expres2ion Biotechnologies ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202312/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202228/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202104/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202003/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05101520253009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 9.2mNo. 390 of 421
Better than 7% of the companies in the industry
EquityDKK 24mNo. 94 of 431
Better than 78% of the companies in the industry
Number of employees20No. 98 of 431
Better than 77% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 9,839of 9,892
Better than 1%
No. 1,483of 9,922
Better than 85%
Same industry and 20–49 employees64 companies in the comparison
No. 49of 62
Better than 21%
No. 32of 64
Better than 51%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 24,744of 24,791
Better than 0%
No. 3,960of 24,909
Better than 84%
All companies of type ApS66,508 companies in the comparison
No. 66,280of 66,379
Better than 0%
No. 3,722of 66,505
Better than 94%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Expres2ion Biotechnologies ApS−DKK 9.2m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Expres2ion Biotechnologies ApS−DKK 21.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Expres2ion Biotechnologies ApSDKK 24m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Expres2ion Biotechnologies ApS20
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Expres2ion Biotech Holding AB100%
Expres2ion Biotechnologies ApS
Subsidiaries and ownership shares

Subsidiaries are shown only if they are in the database.

Management

5 active registrations

Executive management

Executive management at Expres2ion Biotechnologies ApS
NameRoleAppointed
Bent Ulrich FrandsenCEO20/12/2019

Board of directors

Board of directors at Expres2ion Biotechnologies ApS
NameRoleAppointed
Martin Roland JensenChair of the board18/02/2010
Jakob Ole KnudsenBoard member13/06/2018
Karin GarreBoard member02/06/2021
Michel Jean BaijotBoard member01/04/2026
Founders
ApS KBUS 38 nr.3117
Former management (12)
Former management at Expres2ion Biotechnologies ApS
NameRoleAppointedResigned
Peter Andreas StakemannDirector01/01/201018/02/2010
Charlotte DyringBoard member18/02/201016/09/2010
Charlotte DyringDirector18/02/201024/05/2016
Willem Adriaan De JonghBoard member18/02/201016/09/2010
Allan RosetzskyBoard member16/09/201006/10/2022
Martin WelschofBoard member16/09/201021/05/2013
Jesper RoestedBoard member26/05/201126/11/2015
Alexander R DuncanBoard member21/05/201324/05/2016
Steen Søren KlysnerCEO01/04/201620/12/2019
Charlotte DyringBoard member24/05/201601/12/2016
Gitte Laurette Pedersen-BoteroBoard member24/05/201602/06/2021
Sara SandeBoard member02/06/202101/04/2026

Signing rule: Selskabet tegnes af den administrerende direktør eller af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse

Address and production units

1 active production units

Agern Alle 1
2970 Hørsholm

Rudersdal Municipality · Postcode 2970

Other companies at the address (4)

  • CysBio ApSResearch and experimental development on natural sciences and engineering
  • immunAware ApSResearch and experimental development on natural sciences and engineering
  • Tannermedico A/SWholesale of pharmaceutical goods and nursing supplies
  • TOOsonix A/SManufacture of irradiation, electromedical and electrotherapeutic equipment
Production units
Production unitAddressEmployeesP number
EXPRES2ION BIOTECHNOLOGIES ApSAgern Alle 1, 2970 Hørsholm201015842969

Purpose

Selskabets formål er at drive virksomhed indenfor bioteknologi

The purpose is quoted from the register in Danish.

Changes year by year

59 registered events
20263 changesaccounts 1 · management 2
  • Annual report for 2025 published
  • Michel Jean Baijot appointed board member
  • Sara Sande stepped down as board member
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20222 changesmanagement 1 · accounts 1
  • Allan Rosetzsky stepped down as board member
  • Annual report for 2021 published
20214 changesaccounts 1 · management 3
  • Annual report for 2020 published
  • Sara Sande appointed board member
  • Karin Garre appointed board member
  • Gitte Laurette Pedersen-Botero stepped down as board member
20192 changesmanagement 2
  • Bent Ulrich Frandsen appointed ceo
  • Steen Søren Klysner stepped down as ceo
20181 changemanagement 1
  • Jakob Ole Knudsen appointed board member
201611 changescapital 1 · management 6 · ownership 4
  • Share capital changed from 520,835 DKK to 530,835 DKK
  • Charlotte Dyring stepped down as board member
  • Charlotte Dyring appointed board member
  • Gitte Laurette Pedersen-Botero appointed board member
  • Alexander R Duncan stepped down as board member
  • Charlotte Dyring stepped down as director
  • Expres2ion Biotech Holding AB registered as owner (100%)
  • AR CONSULT ApS is no longer registered as owner
  • EXPRES2ION HOLDING ApS is no longer registered as owner
  • AFFITECH A/S is no longer registered as owner
  • Steen Søren Klysner appointed ceo
20156 changesownership 5 · management 1
  • AR CONSULT ApS registered as owner (25%)
  • EXPRES2ION HOLDING ApS registered as owner (33.33%)
  • EXPRES2ION HOLDING ApS is no longer registered as owner
  • VÆKSTFONDEN is no longer registered as owner
  • AR CONSULT ApS is no longer registered as owner
  • Jesper Roested stepped down as board member
20132 changesmanagement 2
  • Alexander R Duncan appointed board member
  • Martin Welschof stepped down as board member
20124 changescapital 1 · ownership 3
  • Share capital changed from 453,126 DKK to 520,835 DKK
  • EXPRES2ION HOLDING ApS registered as owner (25%)
  • VÆKSTFONDEN registered as owner (25%)
  • AR CONSULT ApS registered as owner (15%)
20113 changescapital 1 · address 1 · management 1
  • Share capital changed from 385,417 DKK to 453,126 DKK
  • Moved to Agern Alle 1, 2970 Hørsholm
  • Jesper Roested appointed board member
201017 changescapital 2 · management 10 · ownership 1 · address 2 · name 1 · founded 1
  • Share capital changed from 250,000 DKK to 385,417 DKK
  • Allan Rosetzsky appointed board member
  • Martin Welschof appointed board member
  • Charlotte Dyring stepped down as board member
  • Willem Adriaan De Jongh stepped down as board member
  • Share capital changed from 125,000 DKK to 250,000 DKK
  • AFFITECH A/S registered as owner (20%)
  • Moved to Fremtidsvej 3, 2970 Hørsholm
  • Name changed from ApS KBURS 17 NR. 6965 to EXPRES2ION BIOTECHNOLOGIES ApS
  • Moved to Hannelundsvej 10, 2960 Rungsted Kyst
  • Charlotte Dyring appointed board member
  • Martin Roland Jensen appointed chair of the board
  • Willem Adriaan De Jongh appointed board member
  • Charlotte Dyring appointed director
  • Peter Andreas Stakemann stepped down as director
  • Registered as ApS KBURS 17 NR. 6965
  • Peter Andreas Stakemann appointed director

Related companies

Same industry in Rudersdal

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction